Table 2 Baseline characteristics of the participants
Variable | Value |
|---|---|
Age, years | 45.0 (35.0, 55.0) |
Gender, male, n (%) | 814 (62.8%) |
Weight, kg | 62.0 (54.0, 70.0) |
Height, cm | 165.0 (158.0,170.0) |
Body surface area, m2 | 1.7 ± 0.2 |
Body mass index, Kg/m2 | 22.9 (20.8, 25.4) |
Serum creatinine, mg/dL | 1.5 (1.0, 3.2) |
Serum cystatin C, mg/L | 1.7 (1.1, 2.9) |
rGFR, mL/min/1.73 m2 | 46.8 (29.8, 68.3) |
eGFR, mL/min/1.73 m2 | |
eGFRscr | 49.7 (19.6, 85.8) |
eGFRcys | 40.1 (19.2, 69.3) |
eGFRscr_cys | 44.7 (18.6, 76.5) |
eGFRa_MDRD | 48.9 (20.1, 81.0) |
eGFRc_MDRD | 49.4 (19.1, 85.2) |
eGFR_MDRD | 52.0 (21.6, 88.3) |
rGFR based on CKD stage, mL/min/1.73 m2 | |
Stage 1 (n = 104) | 101.4 (96.2, 111.2) |
Stage 2 (n = 331) | 73.2 ± 8.6 |
Stage 3 (n = 529) | 43.5 (37.0, 51.5) |
Stage 4 (n = 220) | 23.6 (19.5, 27.0) |
Stage 5 (n = 112) | 10.8 (8.5, 13.2) |